<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 life-cycle related proteins are considered promising targets of antiviral drugs. Therefore, molecules and/or products able to inhibit these proteins may be used to treat or even prevent the SARS-CoV-2 infections (
 <xref rid="T1" ref-type="table">
  <bold>Table 1</bold>
 </xref>).
</p>
